Showing results (31-40 of 223) with videos related to
Sort By:
Pageof 23
European Journal of Cancer (Oxford, England : 1990)|November 23, 2013
Open-label, multicentre expansion cohort to evaluate imgatuzumab in pre-treated patients with KRAS-mutant advanced colorectal carcinomaJean-Pierre Delord, Josep Tabernero, Rocío García-Carbonero, et al.Revue De L'Infirmiere|September 15, 2015
[Nurse telephone support at home during chemotherapy]Frédéric Despiau, Marie Bombail, Céline Leches, et al.European Journal of Cancer (Oxford, England : 1990)|September 9, 2017
Phase I study of axitinib and everolimus in metastatic solid tumours and extension to metastatic renal cell carcinoma: Results of EVAX studyAlain Ravaud, Carlos Gomez-Roca, Marie-Quitterie Picat, et al.Surgical Oncology|March 2, 2010
Peritoneal pseudomyxoma arising from the urachusAlejandra Martínez, Gwénael Ferron, Eliane Mery, et al.Current Opinion in Oncology|May 3, 2016
Dermatologic complications of anti-PD-1/PD-L1 immune checkpoint antibodiesVincent Sibaud, Nicolas Meyer, Laurence Lamant, et al.Cancer Chemotherapy and Pharmacology|December 6, 2005
Phase-I study of a new schedule based on increasing days of topotecan administration associated with dose individualisationJean-Pierre Delord, Frédéric Léger, Pierre Canal, et al.Targeted Oncology|November 10, 2020
Selective Oral MEK1/2 Inhibitor Pimasertib: A Phase I Trial in Patients with Advanced Solid TumorsJean-Pierre Delord, Antoine Italiano, Ahmad Awada, et al.Bulletin Du Cancer|November 13, 2022
5-fluorouracil with oxaliplatin and/or irinotecan for advanced sinonasal intestinal-type adenocarcinoma (ITAC)Victor Sarradin, Sarah Betrian, Léonor Chaltiel, et al.Therapie|October 1, 2014
[Cetuximab cutaneous adverse drug reactions: a marker of efficacy for metastatic colorectal cancer and head-neck cancer?]Marlène Soussan-Dahan, Maryse Lapeyre-Mestre, Emmanuelle Bondon-Guitton, et al.Clinical Pharmacokinetics|April 5, 2012
Vinflunine oral pharmacokinetics and absolute bioavailability of soft and hard gelatin capsules: results of two phase I trialsJean-Pierre Delord, Jaafar Bennouna, Loïc Mourey, et al.Pageof 23